Medicare AdvantageCoverageHigh impact
MA08.012d, Off-label Coverage for Prescription Drugs and/or Biologics
Independence Blue Cross·Oncology, Rheumatology, Infectious Disease +1 more·Pharmacy
Effective date
Sep 22, 2025
We identified it
Jun 19, 2026
Summary
Policy MA08.012d establishes new medical necessity criteria for off-label coverage of prescription drugs and biologics under Medicare Advantage plans, effective 09/22/2025. Billing teams must implement prior authorization and documentation requirements to ensure claims for off-label prescriptions meet the updated coverage standards.
Action Required
By 09/22/2025: Billing and prior authorization teams must implement the new medical necessity criteria for all off-label drug and biologic claims under MA08.012d. Update billing software and prior authorization workflows to enforce new criteria before the effective date. Providers must document medical necessity according to the policy requirements for all off-label prescriptions. Claims submitted without proper documentation and prior authorization will be denied. Communicate policy changes to clinical staff and ensure encounter templates capture required documentation elements.